Document Detail


Mechanisms and management of cardiogenic shock.
MedLine Citation:
PMID:  8490760     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiogenic shock remains the most dreaded complication of acute myocardial infarction. Mortality rates remain high despite modern interventional therapy. Patients with a variety of other cardiovascular entities may also develop cardiogenic shock. Management consists of rapid stabilization of systemic arterial blood pressure, expeditious diagnostic evaluation, and definitive therapy when possible. New therapeutic modalities will be needed if patients with cardiogenic shock are to survive.
Authors:
J S Alpert; R C Becker
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical care clinics     Volume:  9     ISSN:  0749-0704     ISO Abbreviation:  Crit Care Clin     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-06-17     Completed Date:  1993-06-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8507720     Medline TA:  Crit Care Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  205-18     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Arizona College of Medicine, Tucson.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Critical Care / methods
Dobutamine / therapeutic use
Dopamine / therapeutic use
Heart Transplantation
Hemodynamics
Humans
Intra-Aortic Balloon Pumping
Monitoring, Physiologic
Myocardial Reperfusion
Shock, Cardiogenic* / diagnosis,  etiology,  therapy
Chemical
Reg. No./Substance:
34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathophysiology and treatment of circulatory shock.
Next Document:  Mechanisms and management of septic shock.